WECHE: a novel hematopoietic regulatory factor.

Area of Science:

• Hematology
• Immunology
• Molecular Biology

Background:

• Endothelial cell lines derived from AGM (Aorto-Gonadal-Mesonephros) can influence hematopoietic cell development.
• Previous research identified specific endothelial cell lines that either inhibit or permit erythroid or B cell development.

Purpose of the Study:

• To identify novel factors regulating hematopoietic differentiation.
• To characterize the function of a newly isolated chemokine, WECHE.

Main Methods:

• Differential gene expression analysis to isolate WECHE from AGM-derived endothelial cells.
• In vitro assays using mouse fetal liver and bone marrow progenitor cells to assess WECHE's effects on hematopoietic colony formation (BFU-E, HPP-CFC).
• Assays to evaluate WECHE's impact on yolk sac-derived endothelial cell growth and its chemotactic activity.

Main Results:

• WECHE was identified as a novel chemokine.
• WECHE specifically inhibited erythroid cell formation (BFU-E development) but did not affect myeloid or B cell formation.
• WECHE reduced high proliferative potential-committed progenitor cell (HPP-CFC) production.
• WECHE hindered the growth of yolk sac-derived endothelial cells.
• WECHE exhibited chemotactic properties for bone marrow cells.

Conclusions:

• WECHE is a novel chemokine that plays a regulatory role in hematopoietic differentiation.
• WECHE influences erythropoiesis and endothelial cell proliferation.
• The findings suggest WECHE is a key regulator in the complex network of hematopoietic stem cell regulation.